Today would have been Bob Saget's 66th birthday. It still seems unimaginable that we would lose him so soon, and all of us at the SRF miss him more than...
Read More
SAN FRANCISCO (May 9, 2022) – The Scleroderma Research Foundation (SRF) will host its inaugural Virtual Patient Forum, Collaborating for a Cure, on Wednesday, June 1, 2022, to kick off...
Read More
Today, we are deeply saddened to learn of the passing of Gilbert Gottfried. He was a good friend of late SRF Board Member Bob Saget, and so he also became…
National Minority Health Month is here. April is an opportunity to raise awareness and encourage advocacy about how health disparities can affect people from racial and ethnic minority groups, including…
We remain overwhelmed by the outpouring of involvement and support from people across the world who are putting their talent and treasure towards the SRF, finding their own personal ways…
Saget’s commitment to building awareness of the disease will continue through support of family, friends, and fans San Francisco, CA (January 13, 2022) – The Scleroderma Research Foundation (SRF)—the country’s...
Read More
It is with a very heavy heart that we mourn the loss of our dear friend and Board member, Bob Saget. Bob was a champion for scleroderma patients everywhere dating...
Read More
As we start 2022, thank you for inspiring all of us at the SRF to remain laser-focused on our mission—finding a cure for scleroderma. And thanks to the support of our…
SRF researchers Michael Longaker, MD, MBA, and Howard Chang, MD, PhD, both of Stanford University, recently published a paper in PNAS on their newly-developed integrated spatial multi-omic analysis platform, which they used to understand...
Read More
This holiday season, we're reflecting with gratitude on the many ways we’ve been able to accelerate the pace of scleroderma research. This is all because of people like YOU. Thanks...
Read More
